A new typeface is making life easier for people everywhere who live with dyslexia. Christian Boer, 33, is a Dutch graphic designer who created the font that makes reading easier for people, like himself, who have dyslexia, according to his website. Now, he’s offering it to people for free.The typeface is called “Dyslexie,” and Boer first developed...
Post
Breakthrough sees new drug for dementia patients which could spell the end to the dangerous ‘chemical cosh’ meds to keep sufferers sedated
Alzheimer’s victims suffer from psychotic episodes and terrifying hallucinations As a result, they are often prescribed anti-psychotic drugs and tranquillisers But in many cases patients are sedated to stop them from wandering off – a practice dubbed the ‘chemical cosh’ A new drug could spell the end of the scandal of dementia patients being prescribed dangerous...
Post
FDA approves admelog for diabetes
(HealthDay)—Admelog (insulin lispro), a short-acting form of insulin, has been approved by the U.S. Food and Drug Administration to treat patients aged 3 years and older with either type of diabetes. Admelog is the first drug approved as a follow-up product based on an abbreviated new process dubbed 505(b)(2), the agency said Monday in a news release....
Post
HOW A ‘BIG BANG’ THEORY COULD CHANGE CANCER TREATMENT
Current treatments involve targeting and killing specific cancer cells, but new research points to the efficacy of an ecological approach to curing the disease. Close-up view of cancer cells. In 1976, Peter Nowell put forth the idea that cancer was more than an overwhelming growth of cells. Just like a family tree, he argued, cancer...
Post
New compound stops progressive kidney disease in its tracks
Progressive kidney diseases, whether caused by obesity, hypertension, diabetes, or rare genetic mutations, often have the same outcome: The cells responsible for filtering the blood are destroyed. Reporting in Science, a team led by researchers from the Broad Institute of MIT and Harvard, Brigham and Women’s Hospital, and Harvard Medical School describes a new approach to...
Post
Platelet-rich plasma injection may be effective for alopecia
(HealthDay)—Subcutaneous injection of platelet-rich plasma (PRP) may be effective for treating alopecia, according to an experimental study published Nov. 11 in the Journal of Cosmetic Dermatology. Sophie Orliac, M.D., from Université Paris Diderot, and colleagues assessed the potential of PRP subcutaneous injection to treat alopecia and to evaluate local toxicity in 12 hairless rats. Subcutaneous injection occurred in...
Post
How cancer could be treated with an old alcoholism drug
Previous studies have demonstrated that the alcohol abuse drug disulfiram has anticancer properties. But until now, researchers had not found the mechanism by which the drug can target cancer. New research sheds light, paving the way for the repurposing of the drug. The drug disulfiram can help to kill off cancer cells. A new study —...
Post
Food? Drug? The FDA says this capsule could cause deadly liver and lung problems
After reports of “two serious and potentially life-threatening medical conditions,” the FDA this week issued a consumer alert for osteoarthritis capsule Limbrel. The alert: Don’t take it. And that came as a surprise to Limbrel manufacturer Primus Pharmaceuticals. “They visited our offices on Nov. 8, as they said in the alert, then spent four days...
Post
Spinal tap needle type impacts the risk of complications
Photo of the two needles used in lumbar puncture: Left: Conventional. Right: Atraumatic The type of needle used during a lumbar puncture makes a significant difference in the subsequent occurrence of headache, nerve irritation and hearing disturbance in patients, according to a study by Hamilton medical researchers. As well, they found the pencil-point atraumatic needle with...
Post
Study finds genetic mutation causes ‘vicious cycle’ in most common form of ALS
IMAGE: PETER TODD, M.D., PH.D.’S UNIVERSITY OF MICHIGAN TEAM FINDS GENETIC MUTATION CAUSES ‘VICIOUS CYCLE’ IN MOST COMMON FORM OF ALS. University of Michigan-led research brings scientists one step closer to understanding the development of neurodegenerative disorders such as ALS. A study published today in Nature Communications details what the researchers describe as a vicious cycle of toxic...